Clinical Trial Update: Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction [Phase 4]

View source ↗

Summary

This document describes a Phase 4 clinical trial comparing prasugrel plus bivalirudin versus clopidogrel plus heparin in myocardial infarction, with no efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Bivalirudin (Angiomax) (bivalirudin)
• Clopidogrel (Plavix) (clopidogrel)
• Heparin (unfractionated heparin)
• Prasugrel (Effient) (prasugrel)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Myocardial Infarction | Phase 4 | Status: UNKNOWN